APOA2 encodes apolipoprotein A-II, a component of HDL cholesterol. A common myth is that a specific variant (rs5082, C allele) directly determines weight loss success. In reality, some studies suggest that C-allele carriers tend to have higher body weight when consuming high saturated fat, while a lower-fat diet may attenuate this effect. However, effect sizes are small and evidence is mixed – many studies fail to replicate the association. Consumer DNA tests can report this variant, but translating it into a personalized diet is not scientifically robust. The gene–environment interaction is complex and overshadowed by total calorie intake, physical activity, and microbiome. Bottom line: APOA2 is not a 'weight loss gene' but a weak modulator of fat metabolism. For weight loss, a calorie-controlled, balanced diet is far more effective than any gene-based approach. Evidence is moderate but not clinically actionable.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-baadf2bd0523b979261c0b27